tbuckley/cabot-search huggingface dataset:
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Authors: Zachary R. McCaw, Lee-Jen Wei
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
P2.01-100 Spectrum of EGFR Exon 20 Insertion Mutations and Co-Occurring Genetic Alterations in Patients with Non-Small-Cell Lung Cancer
Authors: G. Bravo Montenegro, M. Nagasaka, P. Ma, A.R. Naqash, H. Mamdani, A. Spira, D. Subramaniam, R. Feldman, C. Kim
Journal: Journal of Thoracic Oncology (2019)
EP1.04-23 Ongoing Phase II Trial of Anti-PD1 Therapy in Combination with CIMAvax-EGF in Patients with Advanced NSCLC or Squamous Cell Head and Neck Cancer
Authors: G. Dy, T. Crombet, K. Leon, Z. Mazzora, D. Hernandez, A. Lage, A. Dozier, H. Chen, A. Hutson, D. Plessinger, C. Johnson
Journal: Journal of Thoracic Oncology (2019)
OA13.01 SPECS2 Lung Cancer Consortium Prospective Multicenter Validation of Prognostic Signature for Early Stage Squamous Lung Cancer
Authors: R. Bueno, D. Harpole, M. Tsao, D. Beer, M. Watson, F. Shepherd, W. Richards, K. Ballman, X. Wang, Z. Chen, R. Govindan, G. Chen, C. Rivard, F.R. Hirsch
Journal: Journal of Thoracic Oncology (2019)
EP1.01-92 Effectiveness of Second-Line Treatment with Nintedanib + Docetaxel (ND) in Patients with Metastatic Lung Adenocarcinoma
Authors: J.F. Cordoba Ortega, C. Adaniel, S. Morales, A. Gasol, J. Veas, A. Rodriguez, A. Calles Blanco, A. Salud
Journal: Journal of Thoracic Oncology (2019)
P2.17-19 Quality of Life After Pulmonary Stereotactic Fractionated Radiotherapy: Longterm Results of the Phase II STRIPE Trial
Authors: S. Adebahr, U. Nestle, E. Gkika, K. Kaier, T. Schimek-Jasch, M. Hechtner, F. Momm, J. Gaertner, G. Becker, A. Grosu
Journal: Journal of Thoracic Oncology (2019)
P2.01-25 TOURIST: Thoracic Umbrella Radiotherapy Study in Stage IV NSCLC: A Phase III Randomized Trial in Development
Authors: D. Woolf, C. Lee, R. Shah, M. Ahmed, I. Fraser, L. Billingham, I. Phillips, J. Mcaleese, C. Hiley, A. Taylor, L. Calman, B. Rachael, M. Hatton
Journal: Journal of Thoracic Oncology (2019)
Chromosome 1p21 Deletion Defines a Subgroup of Multiple Myeloma with Poor Clinical Outcomes Independent of del (13q), del(p53), t(4;14) or 1q21 Amplification.
Authors: Hong Chang, Connie Qi, Allan Jiang, Wei Xu, Trieu Young, Joe Mikhael, Suzanne Trudel, Christine Chen, Donna Reece
Journal: Blood (2007)
P2.01-88 Molecular Alterations in Cerebrospinal Fluid Predict Clinical Outcomes of Central Nervous System Metastases in Lung Cancer
Authors: M. Zheng, Y. Li, B. Jiang, H. Tu, J. Ye, J. Yang, X. Zhang, S. Chuai, H. Sun, Q. Zhou, W. Zhong, Y. Wu
Journal: Journal of Thoracic Oncology (2019)
EP1.12-30 Clinicopathological Features and Survival of Lung Neuroendocrine Tumors
Authors: M. Galvez Nino, R. Ruiz, J. Moreno, K. Roque Perez, N. Valdivieso, M. Olivera, E. Ferrer, V. Rojas, E. Amorin, J. Montes, L. Mas
Journal: Journal of Thoracic Oncology (2019)
P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial)
Authors: C. Genova, G. Rossi, A. Pezzuto, G. Valmadre, E. Rijavec, F. Biello, G. Barletta, M. Tagliamento, M.G. Dal Bello, S. Boccardo, S. Coco, A. Alama, C. Sini, G. Burrafato, C. Maggioni, E. Bennicelli, L. Cerbone, L. Zullo, A. Ricci, F. Grossi
Journal: Journal of Thoracic Oncology (2019)
P2.04-90 Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
Authors: B. Sepesi, M. Godoy, W. William, A. Vaporciyan, H. Lin, C. Leung, J. Lee, K. Mitchell, A. Weissferdt, X. Le, V. Lam, F. Fossella, S. Swisher, J. Heymach, T. Cascone
Journal: Journal of Thoracic Oncology (2019)
Discovering myeloid cell heterogeneity in the lung by means of next generation sequencing
Authors: Jing-jing Ji, Jie Fan
Journal: Military Medical Research (2019)

Abstract The lung plays a vital role in maintaining homeostasis, as it is responsible for the exchange of oxygen and carbon dioxide. Pulmonary homeostasis is maintained by a network of tissue-resident cells, including epithelial cells, endothelial cells and leukocytes. Myeloid cells of the innate immune system and epithelial cells form a critical barrier in the lung. Recently developed unbiased next generation sequencing (NGS) has revealed cell heterogeneity in the lung with respect to physiology and pathology and has reshaped our knowledge. New phenotypes and distinct gene signatures have been identified, and these new findings enhance the diagnosis and treatment of lung diseases. Here, we present a review of the new NGS findings on myeloid cells in lung development, homeostasis, and lung diseases, including acute lung injury (ALI), lung fibrosis, chronic obstructive pulmonary disease (COPD), and lung cancer.
Insights into Hematopoiesis in GATA2 Deficiency Using Single-Cell Transcriptomics
Authors: Elina A.M. Hirvonen, Inari Natri, Mattila Pirkko, Jenni Lahtela, Pitkänen Esa, Ulla Wartiovaara-Kautto, Outi Kilpivaara
Journal: Blood (2017)
P1.01-127 Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions
Authors: G. Riely, J. Neal, D.R. Camidge, A. Spira, Z. Piotrowska, L. Horn, D. Costa, A. Tsao, J. Patel, S. Gadgeel, L. Bazhenova, V. Zhu, H. West, S. Vincent, J. Zhu, S. Jin, S. Zhang, S. Li, P. Jänne
Journal: Journal of Thoracic Oncology (2019)
EP1.14-04 Validation of New Targets Interfering at Phosphatidylethanolamine Production Against NSCLC
Authors: S. Fernandes Teixeira, L. Inata Mambelli, B. Kawamura, J. Marzagão Barbuto, E. Suavinho Ferro, A. Ferreira
Journal: Journal of Thoracic Oncology (2019)
EP1.12-06 New Treatment Option for ES-SCLC: Patient Characteristics and Use of an Atezolizumab Regimen in the Real-World Setting
Authors: S. Mccune, T. Ton, S. Whipple, R. Induru, L. Horn, I. Percent, T. Mekhail, J. Goldschmidt, T. Leal, G. Macvicar, F. Braiteh, D. Daniel, M. Hussein, A. Mansfield, S. Lam, A. Johnson, S. Morris, A. Spira
Journal: Journal of Thoracic Oncology (2019)
Carcinoma of the Stomach
Authors: J. Morley
Journal: BMJ (1937)

I need not apologize for discussing the problems of cancer of the stomach, for the stomach is by far the commonest seat of cancer in the body.It is true that in the female population the incidence of cancer of the breast is slightly greater; but taking males and females together, in 1934, the last year for which official figures are available, there were in England and Wales 12,269 deaths from cancer of the stomach, as against 6,687 from cancer of the breast.
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms
Authors: Christian A. Di Buduo, Vittorio Abbonante, Caroline Marty, Francesco Moccia, Elisa Rumi, Daniela Pietra, Paolo M. Soprano, Dmitry Lim, Daniele Cattaneo, Alessandra Iurlo, Umberto Gianelli, Giovanni Barosi, Vittorio Rosti, Isabelle Plo, Mario Cazzola, Alessandra Balduini
Journal: Blood (2019)
P2.04-78 PD-L1 Expression as a Prognostic Marker for Non-Small Cell Lung Cancer in Distinct Mutational Status
Authors: N. Trachu, S. Oranratnachai, N. Iemwimangsa, P. Incharoen, S. Detarkom, P. Sanvarinda, W. Chantratita, T. Reungwetwattana
Journal: Journal of Thoracic Oncology (2019)
P1.06-08 WDPM-Like but Not Cribriform as Secondary Growth Patterns Modify Survival in Epithelioid Malignant Pleural Mesothelioma
Authors: Y.Z. Zhang, C. Brambilla, A. Rice, J. Robertus, S. Jordan, E. Lim, L. Lang-Lazdunski, S. Popat, A. Husain, M. Moffatt, W. Cookson, A. Nicholson
Journal: Journal of Thoracic Oncology (2019)
Navigating medicine’s grey areas
Authors: Navjoyt Ladher
Journal: BMJ (2019)

Learning to operate in grey areas is part of the science and art of medicine. As clinicians we must develop the skills to cope with uncertainty and to continuously adapt our practice in response to new information.

Several recent articles should help you navigate some of the grey areas in medicine, from an Analysis that challenges long held views about TB infection being life long (doi:10.1136/bmj.l5770) to …
P2.10-06 Smoking Prevalence and Perceptions Among Healthcare Professionals: A Survey in an Italian Clinical Cancer Centre
Authors: D. Bafunno, A. Catino, V. Lamorgese, D. Galetta, V. Longo, A. Mastrandrea, M. Montrone, F. Pesola, P. Petrillo, P. Pizzutilo, D. Ricci, N. Varesano, A. Zacheo
Journal: Journal of Thoracic Oncology (2019)
Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers
Authors: Zhaoming Wang, Stephen V Rice, Ti-Cheng Chang, Yu Liu, Qi Liu, Na Qin, Daniel K Putnam, Kyla Shelton, Jennifer Q Lanctot, Carmen L Wilson, Kirsten K Ness, Michael C Rusch, Michael N Edmonson, Gang Wu, John Easton, Chimene A Kesserwan, James R Downing, Xiang Chen, Kim E Nichols, Yutaka Yasui, Leslie L Robison, Jinghui Zhang
Journal: JNCI Journal of the National Cancer Institute (2019)

We aimed to systematically evaluate telomere dynamics across a spectrum of pediatric cancers, search for underlying molecular mechanisms, and assess potential prognostic value.The fraction of telomeric reads was determined from whole-genome sequencing data for paired tumor and normal samples from 653 patients with 23 cancer types from the Pediatric Cancer Genome Project. Telomere dynamics were characterized as the ratio of telomere fractions between tumor and normal samples. Somatic mutations were gathered, RNA sequencing data for 330 patients were analyzed for gene expression, and Cox regression was used to assess the telomere dynamics on patient survival.Telomere lengthening was observed in 28.7% of solid tumors, 10.5% of brain tumors, and 4.3% of hematological cancers. Among 81 samples with telomere lengthening, 26 had somatic mutations in alpha thalassemia/mental retardation syndrome X-linked gene, corroborated by a low level of the gene expression in the subset of tumors with RNA sequencing. Telomerase reverse transcriptase gene amplification and/or activation was observed in 10 tumors with telomere lengthening, including two leukemias of the E2A-PBX1 subtype. Among hematological cancers, pathway analysis for genes with expressions most negatively correlated with telomere fractions suggests the implication of a gene ontology process of antigen presentation by Major histocompatibility complex class II. A higher ratio of telomere fractions was statistically significantly associated with poorer survival for patients with brain tumors (hazard ratio = 2.18, 95% confidence interval = 1.37 to 3.46).Because telomerase inhibitors are currently being explored as potential agents to treat pediatric cancer, these data are valuable because they identify a subpopulation of patients with reactivation of telomerase who are most likely to benefit from this novel therapeutic option.
P2.04-72 Clinical Feature and Management of Acquired Resistance to PD-1 Inhibitor in Advanced NSCLC
Authors: S. Okawa, H. Udagawa, T. Naito, K. Kirita, T. Ikeda, Y. Zenke, S. Matsumoto, K. Yoh, S. Niho, K. Goto
Journal: Journal of Thoracic Oncology (2019)
EP1.04-21 Chronic Inflammation as Potential Predictive Factor of Nivolumab Therapy in Non-Small Cell Lung Cancer
Authors: M. Svaton, M. Zemanova, J. Skřičková, V. Kolek, L. Koubkova, F. Salajka, B. Melichar, M. Pesek
Journal: Journal of Thoracic Oncology (2019)
Child maltreatment in sport: smashing the wall of silence: a narrative review of physical, sexual, psychological abuses and neglect
Authors: Kristine Fortier, Sylvie Parent, Geneviève Lessard
Journal: British Journal of Sports Medicine (2019)

Child maltreatment in sport is an undeniable problem. High-profile cases of sexual abuse of child athletes are obvious examples of child maltreatment in this context. Young athletes also face physical and psychological maltreatment, as well as neglect, although these types of child maltreatment are understudied in sport and receive less public attention. Little is known as to how to define physical and psychological maltreatment and neglect in sport and their diverse manifestations. The aim of this paper is to propose concrete manifestations of each type of child maltreatment in sport. We aim to help practitioners better understand and researchers better measure this problem.
MA01.01 Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
Authors: S. Siva, M. Bressel, S. Loi, S. Sandhu, B. Tran, J. Mooi, J. Lewin, A. Azad, D. Colyer, M. Shaw, S. Chander, K. Cuff, S. Wood, N. Lawrentschuk, D. Murphy, D. Pryor
Journal: Journal of Thoracic Oncology (2019)
P1.11-18 The Results of Mandatory Smoking Cessation Intervention in a Population-Based Lung Cancer Screening Trial
Authors: E. Lee, Y. Kim, J. Lee, J. Lim, H.Y. Kim, J.M. Goo, C.T. Lee, S.H. Jang, W.C. Lee, S.W. Sung, C.W. Lee, K.S. Choi, B. Park, D.H. Lee
Journal: Journal of Thoracic Oncology (2019)
P2.06-20 Characterization of Claudin15 as a New Diagnostic Marker for Malignant Pleural Mesotheliomas
Authors: M. Watanabe, T. Higashi, H. Mine, H. Takagi, Y. Ozaki, S. Muto, N. Okabe, T. Hasegawa, Y. Shio, K. Sugimoto, H. Chiba, H. Suzuki
Journal: Journal of Thoracic Oncology (2019)
The Association of Leukocytosis, Thrombocytosis and JAK2V617F Mutation with Thrombotic Events in Myeloproliferative Disorders (MPD’s)
Authors: Madappa N Kundranda, Baidehi Maiti, Nouman Iqbal, Alaa A Muslimani, Asif Chaudhry, Timothy M.D. Spiro, Hamed Daw
Journal: Blood (2008)
JCSE01.10 Efficacy and Safety of Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC)
Authors: N. Li, J. Ying, X. Tao, F. Zhang, Z. Zhao, Y. Ling, Y. Gao, J. Zhao, Q. Xue, Y. Mao, W. Lei, N. Wu, S. Wang, J. Duan, Y. Gao, Z. Wang, N. Sun, J. Wang, S. Gao, J. He, H. Zhou, S. Wang
Journal: Journal of Thoracic Oncology (2019)
P1.06-11 Overlapping Immunophenotypes Between Mesothelioma and Angiosarcoma: Usefulness of Claudin-5 in the Differential Diagnosis
Authors: Y. Nakashima, K. Inamura, H. Ninomiya, S. Kirimura, M. Kobayashi, K. Okubo, Y. Ishikawa
Journal: Journal of Thoracic Oncology (2019)
P1.01-81 A New Prognostic Index Combines the Metabolic Response and RECIST 1.1 to Evaluate the Therapeutic Response in Patients with Lung Cancer
Authors: W. Tang, Q. Hou, J. Lin, Z. Dong, Y. Li, J. Chen, H. Yan, S. Wang, Y. Wu, W. Zhong
Journal: Journal of Thoracic Oncology (2019)
EP1.16-01 A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer: "Circulos Program"
Authors: R. Garcia Campelo, F. Vazquez Rivera, X.L. Firvida, M. Lazaro, S. Vazquez, D. Isla, M. Majem, J. De Castro Carpeno, N. Viñolas
Journal: Journal of Thoracic Oncology (2019)
P2.01-30 Hepatitis B Infection or Aminotransferase Increase Associate with Poor Outcome of Anti-PD-1 Monotherapy in Patients with Advanced NSCLC
Authors: Y. Liu, S. Mao, F. Zhou, A. Xiong, B. Chen, J. Yu, F. Wu, Y. He, G. Gao, X. Chen, C. Su, S. Ren, C. Zhou
Journal: Journal of Thoracic Oncology (2019)
A Man With Incessant Narrow Complex Tachycardia
Authors: Esseim Sharma, Michael Wu
Journal: JAMA (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Monitoring Response to Therapy with Imatinib Mesylate in Chronic Myeloid Leukemia Using Indian Generic Molecule of Imatinib
Authors: Velu Nair, Ajay Sharma, M Bhikshapathy, Deepak Mishra, Satyaranjan Das, Shilajit Bhattacharya, Jyoti Kotwal, Ridhima Dabas, Atul Kotwal, Vinod Raghavan, O. P Mathew
Journal: Blood (2008)
P2.03-23 UHRF1 as a Potential Therapeutic Target for KRAS Mutated Non-Small Cell Lung Cancer
Authors: D. Goto, M. Kizuki, N. Uwatoko, K. Kawai, M. Koike, M. Nakashima, A. Miyazawa, I. Tanaka, T. Hase, M. Morise, Y. Hasegawa, J. Minna, M. Sato
Journal: Journal of Thoracic Oncology (2019)
Lack of paediatric experts to testify in cases of suspected child harm is traumatising families, says judge
Authors: Clare Dyer
Journal: BMJ (2019)

Justice is being delayed and families traumatised because there are too few paediatric experts willing to give evidence in cases where local authorities accuse parents of harming a child, a family court judge has said.1

Judge Robin Bedford made the comments in a case which went to the family court at Brighton because social services believed that a three month old baby, referred to as C, had suffered a non-accidental injury (NAI). Mother and baby were required to go into a foster placement while the three other children remained at home with their father under supervision.

It took five months before the family were reunited after three independent paediatric experts agreed that the baby had had an accidental low level fall. At one point, the local authority applied to the court for an order that the three other children should go into foster …
P2.04-51 A 6-Gene Immune Genomic Signature (IGS) Predicts Resistance to Nivolumab [NIV] in Advanced Pretreated NSCLC: Results of PRINCiPe Trial
Authors: S. Pilotto, V. Di Noia, I. Sperduti, G. Grizzi, E. D'Argento, M. Simbolo, C. Vicentini, A. Caliò, A. Mafficini, L. Carbognin, V. Corbo, A. Gkountakos, E. Vita, A. Santo, M. Brunelli, M. Martini, A. Scarpa, M. Milella, G. Tortora, E. Bria
Journal: Journal of Thoracic Oncology (2019)
Response to “International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder” by Guu et al. (2019)
Authors: Carisha S. Thesing, Femke Lamers, Mariska Bot, Brenda W.J.H. Penninx, Yuri Milaneschi
Journal: Psychotherapy and Psychosomatics (2019)
Abnormal Activity of Neck Inspiratory Muscles during Sleep as a Prognostic Indicator in Chronic Obstructive Pulmonary Disease
Authors: Stefania Redolfi, Leo Grassion, Isabelle Rivals, Mario Chavez, Nicolas Wattiez, Isabelle Arnulf, Jesus Gonzalez-Bermejo, Thomas Similowski
Journal: American Journal of Respiratory and Critical Care Medicine (2019)

Rationale: In patients with chronic obstructive pulmonary disease (COPD), increased activity of neck inspiratory muscles has been reported as a compensatory response to hyperinflation-related diaphragmatic dysfunction. The persistence of this activity during sleep could attenuate sleep-related hypoventilation and also negatively impact sleep and clinical outcomes.Objectives: To assess the persistence of neck-muscle activity during sleep in patients with COPD recovering from severe exacerbations (i.e., requiring hospitalization) and its impact on sleep quality and recurrence of exacerbations.Methods: Video polysomnography with neck-muscle EMG was performed in patients with COPD who were recovering from a severe exacerbation. The follow-up period lasted 6 months to record the next severe exacerbation.Measurements and Main Results: Twenty-nine patients were included in the study (median [25th-75th percentile] age, 71 [64-72] yr; 55% male; body mass index, 24 [21-29]; FEV1% predicted, 37 [29-45]; and BODE [body mass index, airflow obstruction, dyspnea, and exercise] index, 6 [5-7]). Twenty-six of these patients exhibited sleep-related neck-muscle activity, which was intermittent (limited to stage 3 sleep) in 17 and permanent throughout sleep in 9. α-Delta EEG activity during stage 3 sleep was observed in 87% of the patients. Compared with patients with no or intermittent neck-muscle activity, those with permanent neck-muscle activity showed more disrupted sleep, had experienced more exacerbations in the previous year, and suffered their next severe exacerbation earlier.Conclusions: Sleep-related neck-muscle activity occurs frequently in patients with COPD who are recovering from a severe exacerbation and seems to negatively affect sleep quality and prognosis; therefore, identification of this activity might improve COPD management after a severe exacerbation.
Near-infrared light and glucose dual-responsive cascading hydroxyl radical generation for in situ gelation and effective breast cancer treatment
Authors: Yu Hao, Ziliang Dong, Muchao Chen, Yu Chao, Zhuang Liu, Liangzhu Feng, Y. Hao, Z.L. Dong, M.C. Chen, Y. Chao, Z. Liu, L.Z. Feng
Journal: Biomaterials (2019)
P2.08-02 Outcomes Following Stereotactic Radiosurgery for Syncronous Brain Metastases in Non-Small Cell Lung Cancer
Authors: F. Wilson, S. Yousif, Y. Li, N. Bayman, C. Chan, D. Cobben, R. Colaco, J. Coote, C. Faivre-Finn, R. Gattamaneni, M. Harris, A. Hudson, L. Pemberton, A. Salem, H. Sheikh, A. Tran, G. Whitfield, C. Mcbain, D. Woolf
Journal: Journal of Thoracic Oncology (2019)
P2.04-12 Ph I Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and SBRT to Multiple Sites in Patients with Stage IV NSCLC
Authors: J. Patel, M. Jelinek, C. Bestvina, S. Pitroda, E. Vokes, S. Chmura
Journal: Journal of Thoracic Oncology (2019)
MA13.10 A Phase II Study of Carboplatin and Nab-Paclitaxel for Advanced Non-Small Cell Lung Cancer with Interstitial Lung Disease (HOT1302)
Authors: H. Yokouchi, H. Asahina, S. Oizumi, K. Takamura, T. Harada, M. Harada, K. Kanazawa, Y. Fujita, T. Kojima, F. Sugaya, H. Tanaka, R. Honda, T. Ogi, E. Kikuchi, T. Ikari, H. Dosaka-Akita, H. Isobe, M. Nishimura
Journal: Journal of Thoracic Oncology (2019)